Reckitt Benckiser (RB.LSE) announced it plans to proceed with a spinoff of its pharmaceutical business, Indivior, to existing shareholders on 12/23 if the plan is approved by shareholders at a special meeting on 12/11. The spinoff would allow RB to focus on its core consumer health and hygiene business such as Clearasil acne treatments, Lysol cleaning products and Durex condoms. Source: NYTIMES
Spin-Off
